NeoGenomics (NEO)
(Real Time Quote from BATS)
$16.04 USD
-0.24 (-1.47%)
Updated Sep 23, 2024 02:58 PM ET
3-Hold of 5 3
C Value A Growth B Momentum B VGM
Brokerage Reports
0 items in cart
NeoGenomics, Inc. [NEO]
Reports for Purchase
Showing records 1 - 20 ( 132 total )
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Optimized Entry and Exit Levels for NEO 112223
Provider: Stock Traders Daily
Analyst: Research Department
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
We are dropping coverage of the following stocks
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Dropping Coverage due to reallocate our research resources.
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
2018 Top Stock Picks
Provider: G.RESEARCH, LLC
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Healthcare - Coverage Update - Healthcare Sector
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Transferring Coverage due to the departure of the covering analyst
Provider: Roth Capital Partners, Inc.
Analyst: HENRY S
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
We are placing shares of NEO Under Review, and transferring coverage to Scott Henry, CFA due to the departure of the covering analyst.
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Solid 2Q on Strong Volume Growth, Pharma Acceleration
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Analyst Day Takeaways - Integration Now Complete, Time to Realize Benefits
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
MORNING SUMMARY
Provider: Roth Capital Partners, Inc.
Company: NeoGenomics, Inc.
Industry: Medical - Biomedical and Genetics
Despite Disruptions, Integration Now\ Complete - Table Set for Synergies
Provider: Roth Capital Partners, Inc.
Analyst: LEWIS C